Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Biocon chief Kiran Mazumdar Shaw's husband passes away

Shaw was admitted to the hospital where he was undergoing treatment, they said.&nbsp;The exact reason behind the death was not known.

Biocon executive chairperson Kiran Mazumdar Shaw's husband John Shaw passed away on Monday morning in a private hospital, family sources said. He was 73.
Shaw was admitted to the hospital where he was undergoing treatment, they said.
The exact reason behind the death was not known.
Shaw was the former vice chairman of the Bengaluru-headquartered Biocon Limited.
Also watch: <a href="https://www.editorji.com/business-news/resolve-religious-divide-will-ruin-it-leadership-biocon-chief-tells-karanataka-cm-1648721424374">'Resolve religious divide...will ruin IT leadership': Biocon chief tells Karnataka CM</a>
He was an MA (Economics Honours) in History and Political Economy from the University of Glasgow in United Kingdom.
He was also the former chairman of Madura Coats Limited and former finance and managing director of Coats Viyella Group.

Hitting out strongly against media reports alleging bribery charges favouring Biocon's unit, Kiran Mazumdar-Shaw took to Twitter to not only deny the allegations but also to shut down trolls. Shaw took an aggressive stance to safeguard the integrity of Biocon as she reminded netizens to read and understand before spreading fake news. The founder of Biocon denied all allegations of wrong doing reported in a PTI news copy that had alleged a 4 lakh bribe was given to a drug controller to waive off a critical insulin trial. Citing procedure Kiran Mazumdar Shaw explained that "The product is EU approved n has conducted full trials globally. All that has been sought is an India trial waiver OK? Pls understand facts before jumping to conclusions. CDSCO provides for trial waiver for EU n US approved products."Biocon Biologics - the unit under question has also issued a statement denying all allegations and is cooperating with CBI as all material and filings are available online with minutes of meetings as well. 

Kiran Mazumdar-Shaw hit back on bribe allegations, strongly denies reports

Kiran Mazumdar-Shaw hit back on bribe allegations, trial waiver was procedural

Kiran Mazumdar-Shaw hits back on bribe allegations, trial waiver was procedural

The CBI registered a case of criminal conspiracy and corruption against Reddy, posted at CDSCO headquarters, and Dinesh Dua, Director at Synergy Network India Private Limited, among others

Hitting out strongly against media reports alleging bribery charges favouring Biocon's unit, Kiran Mazumdar-Shaw took to Twitter to not only deny the allegations but also to shut down trolls.&nbsp; Shaw took an aggressive stance to safeguard the integrity of Biocon as she reminded netizens to read and understand before spreading fake news. The founder of Biocon denied all allegations of wrong doing reported in a PTI news copy that had alleged a 4 lakh bribe was given to a drug controller to waive off a critical insulin trial.&nbsp;
Also read/watch| <a title="&nbsp;Bribe allegations on Biocon's injection unit, Joint drugs controller arrested" href="https://www.editorji.com/business-news/bribe-allegations-on-biocon-s-injection-unit-joint-drugs-controller-arrested-1655783902630">&nbsp;Bribe allegations on Biocon's injection unit, Joint drugs controller arrested</a> Citing procedure Kiran Mazumdar Shaw explained that "The product is EU approved n has conducted full trials globally. All that has been sought is an India trial waiver OK? Pls understand facts before jumping to conclusions. CDSCO provides for trial waiver for EU n US approved products." Biocon Biologics - the unit under question has also issued a statement denying all allegations and is cooperating with CBI as all material and filings are available online with minutes of meetings as well.&nbsp;

Alleging charges of bribe in a case involving a unit of Kiran Mazumdar-Shaw backed Bicon, the Central Bureau of Investigation has arrested a Joint Drug Controller (JDC) and also a Director of Synergy Network India. 
As per reports the agency laid a trap wherein the JDC of CDSCO was caught while accepting a bribe of Rs 4 lakh from the Director of Synergy Network India Private Limited. The said Director was also caught.The bribe reportedly was to clear Biocon unit's injection by waiving phase-three clinical trial of Insulin Aspart injection, an underdevelopment product of Biocon Biologics"Phase 3 clinical trial is an important regulatory mechanism to assess the safety of a pharma product. Any attempt to waive them off can have serious public health safety repercussions," an official said
Searches were conducted at 11 places located at Delhi, Noida, Gurugram, Patna and Bengaluru. The agency claims to have recovered alleged incriminating documents/articles.
Denying allegations of any wrongdoing, a spokesperson for Biocon Biologics said "All our product approvals are legitimate and backed by science and clinical data. Our bAspart is approved in Europe and many other countries. We follow due regulatory process for all our product approvals by DCGI. The entire application process in India is online and all meeting minutes are in public domain. We are co-operating with the investigation agency."

Bribe allegations on Biocon's injection unit, Joint drugs controller arrested

The bribe reportedly was to clear Biocon unit's injection by waiving phase-three clinical trial of Insulin Aspart injection, an underdevelopment product of Biocon Biologics

Drug controller's office bribed to waive off crucial part of insulin trial? 

A total of six accused have been booked by the CBI including &ldquo;unknown officials of CDSCO&rdquo;

Alleging charges of bribe in a case involving a unit of Kiran Mazumdar-Shaw backed Bicon, the Central Bureau of Investigation has arrested a Joint Drug Controller (JDC) and also a Director of Synergy Network India.&nbsp;
As per reports, the agency laid a trap wherein the JDC of CDSCO was caught while accepting a bribe of Rs 4 lakh from the Director of Synergy Network India Private Limited. The said Director was also caught. The bribe reportedly was to clear Biocon unit's injection by waiving phase-three clinical trial of Insulin Aspart injection, an underdevelopment product of Biocon Biologics.&nbsp;
Also read/watch| <a title="No wrong doing! Kiran Mazumdar-Shaw lashes out, waiver was procedural&nbsp;" href="https://www.editorji.com/business-news/no-wrong-doing-kiran-mazumdar-shaw-lashes-out-waiver-was-procedural-1655788892026">No wrong doing! Kiran Mazumdar-Shaw lashes out, waiver was procedural&nbsp;</a> "Phase 3 clinical trial is an important regulatory mechanism to assess the safety of a pharma product. Any attempt to waive them off can have serious public health safety repercussions," an official said
Searches were conducted at 11 places located at Delhi, Noida, Gurugram, Patna and Bengaluru. The agency claims to have recovered alleged incriminating documents/articles.
Denying allegations of any wrongdoing, a spokesperson for Biocon Biologics said "All our product approvals are legitimate and backed by science and clinical data. Our bAspart is approved in Europe and many other countries. We follow the due regulatory process for all our product approvals by DCGI. The entire application process in India is online and all meeting minutes are in the public domain. We are co-operating with the investigation agency." - With Inputs from PTI &amp; ET

Give Covid-19 vaccine to the young before elderly: Kiran Mazumdar-Shaw

Kiran Mazumdar Shaw is clear about the responsibility of Pharma companies. She says they don't have the luxury to be selective about what data they share with the public, simply because public money is involved. This EXCLUSIVE interview to Govindraj Ethiraj delves into who should get vaccines first - the young or the vulnerable?&nbsp;
- Whether it's possible to shrink the regulatory processes and timelines in vaccine or drug delivery for emergency use?
- Challenges of managing multiple vaccine deliveries with our constrained public health resources
- The need for a Pandemic Preparedness Technology Platform,
- Ongoing public health challenges triggered by the pandemic and our attempts at meeting them.
- How innovation can tackle a public health crisis like Covid19.
Referring to her own experience with Biocon's Itolizumab - a drug that ultimately did not become a part of Covid19 clinical management protocol, she says they got emergency use authorisation because, "We were able to demonstrate safety and showed some amount of efficacy".

biocon

Categories